Literature DB >> 15319322

Diagnostic accuracy of cystatin C as a marker of kidney disease in patients with multiple myeloma: calculated glomerular filtration rate formulas are equally useful.

Edmund J Lamb1, Helen J Stowe, David E Simpson, Anthony J Coakley, David J Newman, Maeve Leahy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15319322     DOI： 10.1373/clinchem.2004.036947

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

1.  Serum cystatin C as a marker to identify patients with moderately impaired renal function.

Authors:  H Peiris; L G Chandrasena; R D Lanerolle
Journal:  Indian J Clin Biochem       Date:  2008-06-11

2.  Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.

Authors:  Evangelos Terpos; Eirini Katodritou; Evangelos Tsiftsakis; Efstathios Kastritis; Dimitrios Christoulas; Anastasia Pouli; Eurydiki Michalis; Evgenia Verrou; Konstantinos Anargyrou; Konstantinos Tsionos; Meletios A Dimopoulos; Konstantinos Zervas
Journal:  Haematologica       Date:  2009-03       Impact factor: 9.941

3.  Factors other than the glomerular filtration rate that determine the serum beta-2-microglobulin level.

Authors:  Zeno Stanga; Stefan Nock; Pedro Medina-Escobar; Urs E Nydegger; Martin Risch; Lorenz Risch
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

4.  Cystatin C-Based Equations Detect Hidden Kidney Disease and Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.

Authors:  Francisco-Javier Cepeda-Piorno; Esther González-García; Alba Méndez-Gallego; Juan Torres-Varona; Vanesa García-Moreira; Christian Sordo-Bahamonde; Cristina AlberdiGarcía-Del-Castillo; Elene Astobieta-Madariaga; Maria-Victoria Mateos-Manteca; Segundo González-Rodríguez
Journal:  Adv Hematol       Date:  2022-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.